These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 36635772)
1. CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia. Hu X; Han Y; Liu J; Wang H; Tian Z; Zhang X; Zhang Y; Wang X Exp Hematol Oncol; 2023 Jan; 12(1):6. PubMed ID: 36635772 [TBL] [Abstract][Full Text] [Related]
2. CTP Synthase 2 From Hickl D; Scheuring D; Möhlmann T Front Plant Sci; 2021; 12():652434. PubMed ID: 33936137 [TBL] [Abstract][Full Text] [Related]
3. Differential roles of CTP synthetases CTPS1 and CTPS2 in cell proliferation. Minet N; Boschat AC; Lane R; Laughton D; Beer P; Asnagli H; Soudais C; Bourne T; Fischer A; Martin E; Latour S Life Sci Alliance; 2023 Sep; 6(9):. PubMed ID: 37348953 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia. Zhang Y; Zhou X; Li Y; Xu Y; Lu K; Li P; Wang X Oncogene; 2018 Oct; 37(41):5520-5533. PubMed ID: 29895969 [TBL] [Abstract][Full Text] [Related]
5. The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia. Miller CR; Ruppert AS; Fobare S; Chen TL; Liu C; Lehman A; Blachly JS; Zhang X; Lucas DM; Grever MR; Tallman MS; Flinn IW; Rassenti LZ; Kipps TJ; Sampath D; Coombes KR; Hertlein EK Oncotarget; 2017 Apr; 8(16):25942-25954. PubMed ID: 28412730 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival. Liang JH; Wang C; Yiu SPT; Zhao B; Guo R; Gewurz BE mBio; 2021 Aug; 12(4):e0153021. PubMed ID: 34281398 [TBL] [Abstract][Full Text] [Related]
7. Cytosolic CTP Production Limits the Establishment of Photosynthesis in Bellin L; Scherer V; Dörfer E; Lau A; Vicente AM; Meurer J; Hickl D; Möhlmann T Front Plant Sci; 2021; 12():789189. PubMed ID: 34917117 [TBL] [Abstract][Full Text] [Related]
8. CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation. Martin E; Palmic N; Sanquer S; Lenoir C; Hauck F; Mongellaz C; Fabrega S; Nitschké P; Esposti MD; Schwartzentruber J; Taylor N; Majewski J; Jabado N; Wynn RF; Picard C; Fischer A; Arkwright PD; Latour S Nature; 2014 Jun; 510(7504):288-92. PubMed ID: 24870241 [TBL] [Abstract][Full Text] [Related]
9. HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemia. Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL J Transl Med; 2021 Jan; 19(1):42. PubMed ID: 33485349 [TBL] [Abstract][Full Text] [Related]
10. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia. Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084 [TBL] [Abstract][Full Text] [Related]
11. Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia? Rozovski U; Keating MJ; Estrov Z Acta Haematol; 2018; 140(1):51-54. PubMed ID: 30114695 [TBL] [Abstract][Full Text] [Related]
13. Chloroplast quality control pathways are dependent on plastid DNA synthesis and nucleotides provided by cytidine triphosphate synthase two. Alamdari K; Fisher KE; Tano DW; Rai S; Palos K; Nelson ADL; Woodson JD New Phytol; 2021 Aug; 231(4):1431-1448. PubMed ID: 33993494 [TBL] [Abstract][Full Text] [Related]
15. Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib. Guo A; Lu P; Galanina N; Nabhan C; Smith SM; Coleman M; Wang YL Oncotarget; 2016 Jan; 7(4):4598-610. PubMed ID: 26717038 [TBL] [Abstract][Full Text] [Related]
16. T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients. Damle RN; Temburni S; Banapour T; Paul S; Mongini PK; Allen SL; Kolitz JE; Rai KR; Chiorazzi N Blood; 2012 Sep; 120(12):2438-49. PubMed ID: 22875913 [TBL] [Abstract][Full Text] [Related]
17. Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia. Liang T; Wang X; Liu Y; Ai H; Wang Q; Wang X; Wei X; Song Y; Yin Q Front Immunol; 2022; 13():985280. PubMed ID: 36211334 [TBL] [Abstract][Full Text] [Related]